Browsing by Titles

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 2 of 2

The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta

Article
The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta
  • Chae, Sehyun ; 
  • Lee, Hyun-ju ; 
  • Lee, Ha-Eun ; 
  • Kim, Jieun ; 
  • Jeong, Yoo Joo ; 
  • Lin, Yuxi ; 
  • Kim, Hye Yun ; 
  • Leriche, Geoffray ; 
  • Ehrlich, Rachel S. ; 
  • Lingl, Sascha Castro ; 
    • et al
  • 2024-08
  • Chae, Sehyun. (2024-08). The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta. Journal of Neuroinflammation, 21(1). doi: 10.1186/s12974-024-03180-x
  • BioMed Central
  • View : 256
  • Download : 44
Article
The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation
  • Lee, Hyun-ju ; 
  • Woo, Hanwoong ; 
  • Lee, Ha-Eun ; 
  • Jeon, Hyongjun ; 
  • Ryu, Ka-Young ; 
  • Nam, Jin han ; 
  • Jeon, Seong Gak ; 
  • Park, HyunHee ; 
  • Lee, Ji-Soo ; 
  • Han, Kyung-Min ; 
    • et al
  • 2020-11
  • Lee, Hyun-ju. (2020-11). The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation. doi: 10.1016/j.freeradbiomed.2020.08.030
  • Elsevier Inc.
  • View : 580
  • Download : 0
1